FARAONI, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 10.347
AS - Asia 1.154
EU - Europa 1.086
SA - Sud America 223
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 12.833
Nazione #
US - Stati Uniti d'America 10.291
SG - Singapore 568
CN - Cina 244
IT - Italia 195
BR - Brasile 192
DE - Germania 190
UA - Ucraina 141
HK - Hong Kong 137
IE - Irlanda 116
GB - Regno Unito 103
RU - Federazione Russa 71
SE - Svezia 70
FR - Francia 67
VN - Vietnam 67
FI - Finlandia 45
CA - Canada 38
KR - Corea 32
IN - India 25
PL - Polonia 17
BE - Belgio 16
NL - Olanda 16
ID - Indonesia 15
JP - Giappone 15
AR - Argentina 13
BD - Bangladesh 12
MX - Messico 12
AT - Austria 11
ZA - Sudafrica 9
ES - Italia 8
AL - Albania 7
CO - Colombia 7
KG - Kirghizistan 5
EC - Ecuador 4
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
IL - Israele 3
IQ - Iraq 3
LB - Libano 3
SA - Arabia Saudita 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
EG - Egitto 2
EU - Europa 2
KE - Kenya 2
KW - Kuwait 2
LU - Lussemburgo 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PK - Pakistan 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
VE - Venezuela 2
CL - Cile 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
LT - Lituania 1
MD - Moldavia 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 12.833
Città #
Woodbridge 2.859
Houston 2.624
Wilmington 2.459
Ann Arbor 314
Singapore 292
Ashburn 202
Chandler 196
Fairfield 193
Hong Kong 135
Jacksonville 123
Beijing 113
New York 98
Dublin 95
Dearborn 92
Seattle 83
Cambridge 75
Medford 75
Rome 61
Santa Clara 51
Dallas 50
The Dalles 48
Council Bluffs 37
Los Angeles 37
Lawrence 34
Ho Chi Minh City 23
Mülheim 23
Buffalo 21
Menlo Park 21
Munich 18
San Diego 17
Boardman 16
Brussels 16
Del Norte 16
Falls Church 16
Ottawa 16
São Paulo 16
Palo Alto 14
Hangzhou 13
Hanoi 13
Jakarta 13
Milan 13
Moscow 12
Zhengzhou 12
Frankfurt am Main 11
Helsinki 11
Kraków 11
Redondo Beach 11
Nuremberg 9
Redwood City 9
Chicago 8
Curitiba 8
Dong Ket 8
Engelhard 8
Salt Lake City 8
University Park 8
Belo Horizonte 7
Boston 7
Brooklyn 7
Mountain View 7
Phoenix 7
Seoul 7
Vienna 7
Florence 6
Montreal 6
Nanjing 6
San Jose 6
Tokyo 6
Toronto 6
Brasília 5
Guangzhou 5
Hyderabad 5
Johannesburg 5
London 5
Marseille 5
Norwalk 5
Orem 5
Rio de Janeiro 5
Turku 5
Verona 5
Warsaw 5
Contagem 4
Hefei 4
Mexico City 4
Perugia 4
Poplar 4
Shanghai 4
Tirana 4
Washington 4
Amsterdam 3
Brno 3
Campinas 3
Castelfidardo 3
Collegno 3
Columbus 3
Fonte Nuova 3
Grasse 3
Hebei 3
Itaquaquecetuba 3
Kunming 3
Lappeenranta 3
Totale 10.978
Nome #
BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib. 495
Preclinical studies on detection of circulating melanoma cells in patients: Telomerase as a recognition marker of malignancy 480
AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro 475
Comparative antiviral and antiproliferative activity of PGA1 and PGJ2 against HTLV-1-infected MT-2 cells. 456
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro 454
Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells 443
COMPARATIVE ANTIVIRAL AND ANTIPROLIFERATIVE ACTIVITY OF PGA1 AND PGJ2 AGAINST HTLV-I-INFECTED MT-2 CELLS 428
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype 427
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro 415
Inhibition of O-6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic coils to apoptosis induced by temozolomide 413
Modulation of GDF11 expression and synaptic plasticity by age and training 411
Telomerase as a potential anticancer target: growth inhibition and genomic instability 410
Effect of beta interferon on HTLV I infection of fractionated T cells 401
Clinical applications of telomerase in cancer treatment 395
In vitro measurement of ovarian cancer cells chemosensitivity to antineoplastic drugs as inhibition of telomerase activity 384
Stem cell factor activates telomerase in mouse mitotic spermatogonia and in primordial germ cells 378
Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples 371
Telomerase as a marker of tumor cell viability: A new approach for in vitro chemosensitivity assays? 371
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia 369
Development of a novel in vitro chemosensitivity assay: telomerase as a possible marker of tumor cell survival 366
Transient HTLV-I infection of a human glioma cell line following cell-free exposure 362
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status. 342
Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-Ribose) polymerase 341
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 341
The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation. 329
Stem cell factor activates telomerase in mouse mitotic spermatogonia and in primordial germ cells 326
PROTECTIVE EFFECT OF INTERFERON-BETA ON HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I INFECTION OF CD4+ T-CELLS ISOLATED FROM HUMAN CORD-BLOOD 307
Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes 281
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line 263
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies 230
Role of BRCA mutations in cancer treatment with poly(ADP-ribose) polymerase (PARP) inhibitors 214
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders 167
Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers 149
Abscopal effect and drug-induced xenogenization: a strategic alliance in cancer treatment? 139
Poly(ADP-Ribose) polymerase inhibitors for arsenic trioxide-resistant acute promyelocytic leukemia: synergistic in vitro antitumor effects with hypomethylating agents or high-dose vitamin C 102
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia 102
High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients 87
Polydatin-Induced Shift of Redox Balance and Its Anti-Cancer Impact on Human Osteosarcoma Cells 73
Combination treatment of resistant acute promyelocytic leukemia cells with arsenic trioxide and anti-apoptotic gene inhibitors 56
miR-155 gene: A typical multifunctional microRNA 51
HSP70 production and inhibition of cell proliferation in molt-4 T-cells after cell-to-cell transmission of HTLV-I: Effect of PGA1 47
A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro 42
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation 42
Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro 39
In vitro chemosensitivity of neoplastic cells: Telomerase as a possible marker of tumor cell survival 38
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias 36
Nerve growth factor induces the re-expression of functional androgen receptors and p75NGFR in the androgen-insensitive prostate cancer cell line DU145 36
Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines 35
Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene 32
Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications 27
Totale 12.978
Categoria #
all - tutte 29.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021822 0 0 0 0 0 180 223 189 41 62 84 43
2021/2022440 25 37 29 38 25 40 28 27 26 32 28 105
2022/2023492 44 41 7 81 46 110 49 21 40 1 31 21
2023/2024321 21 6 23 3 32 114 15 6 5 5 45 46
2024/20251.132 110 198 97 52 34 73 90 80 163 65 84 86
2025/2026996 203 110 259 173 202 49 0 0 0 0 0 0
Totale 12.978